Table 3. Energy metabolism markers.
| Groups | P values | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| SA0 (n = 8) | SA2 (n = 8) | SA5 (n = 8) | IA0 (n = 8) | IA2 (n = 8) | IA5 (n = 8) | P (I) | P (A) | P (IxA) | |
| β-OHADH (nmol/g) | 33.1±2.02 | 33.6±1.87 | 37.2±1.54 | 20.2±1.45 | 19.0±1.6 | 24.6±1.41 | <0.0011 | 0.0142 | 0.823 |
| #LDH (nmol/g) | 70.3±2.66a | 81.1±7.27 | 65.6±6.42 | 139±6.39a,A,C | 70.1±1.77A | 65.4±2.16C | <0.005 | 0.880 | <0.0053 |
| #PFK (nmol/g) | 143±5.9 | 141±9.2 | 133±9.1 | 155±4.67 | 152±5.4 | 143±9.2 | 0.129 | 0.939 | 0.447 |
| PDH (nmol/g) | 286±12.1 | 300±15.5 | 317±15.5 | 218±15.4 | 293±15.6 | 298±11.4 | 0.0111 | <0.0012 | 0.085 |
| *CS (nmol/g) | 86.3±8.15 | 108±10.2 | 131±9.87 | 51.8±2.37 | 62.6±5.27 | 62.6±3.95 | <0.0011 | 0.0022 | 0.291 |
| *complex I (nmol/g) | 5.19±0.07a | 4.99±0.14b | 5.11±0.10 | 3.39±0.29a,C | 3.37±0.35b,B | 4.78±0.22B,C | <0.001 | 0.015 | 0.0153 |
| complex II (nmol/g) | 5.54±0.34 | 4.66±0.34 | 4.73±0.31 | 3.09±0.16 | 2.99±0.18 | 3.48±0.25 | <0.0011 | 0.208 | 0.094 |
| ATP synthase (nmol/g) | 37.4±0.91a, E | 35.9±1.16b,D | 31.4±1.39c,D,E | 20.6±1.01a | 21.9±1.06b | 20.1±0.98c | <0.001 | 0.007 | 0.049 |
I: infarction; S: sham; A: açai; A0: no supplementation; A2: 2% açai supplementation; A5: 5% açai supplementation. β-OHADH: β-hydroxyacyl coenzyme-A dehydrogenase; LDH: lactate dehydrogenase; PFK: Phosphofructokinase; PDH: pyruvate dehydrogenase complex; CS: citrate synthase. Data are expressed as mean ± SEM. Bold numbers represents significant effects considered.
1 Comparisons for I factor: infarcted animals different from sham animals.
2 Comparisons for açai factor, β-OHADH: animals A0≠animals A5 and animals A2≠animals A5; PDH: animals A0≠animals A2 and animals A0≠animals A5; CS: animals A0≠animals A2 and animals A0≠animals A5.
3 IxA: when interactions are observed, same superscript letters represents differences (P<0.05).
*variables normalized for 2-factor ANOVA test.
#Mann Whitney and Kruskal Wallis.